SavedAdd your journal

Journals / Sağlık Bilimlerinde İleri Araştırmalar Dergisi / 2022 / Cilt: 5 - Sayı: 3

GENETIC AND CLINICAL PROFILING OF MENDELIAN SUSCEPTIBILITY TO MYCOBACTERIAL DISEASE PATIENTS; SINGLECENTER EXPERIENCE

MİKOBAKTERİYEL HASTALIKLARA MENDEL DUYARLILIĞI HASTALARININ GENETİK VE KLİNİK PROFİLİ; TEK MERKEZ DENEYİMİ

Serdar NEPESOV
Sinem FIRTINA
Deniz AYGÜN
Begüm IŞIKGİL
Yıldız CAMCIOĞLU
Ayça KIYKIM
Esra ÖZEK
Yasemin KENDİR DEMİRKOL
Akif AYAZ
Pages
140–146
Publication Date
2022-11-16
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The deficiency of IFN-mediated immunity genes plays a crucial role in the pathogenesis of MSMD and must be considered in pediatric patients with BCGitis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Mendelian susceptibility to mycobacterial disease (MSMD) is a subgroup of primary immunodeficiencies which develops with the Bacille Calmette–Guérin (BCG) vaccine or non-tuberculous mycobacterial infections.
📊
Key Findings & Data:Materials and Methods: Herein, we performed whole-exome sequencing (WES) on 13 patients with MSMD phenotype.
💡
Conclusion & Impact:The deficiency of IFN-mediated immunity genes plays a crucial role in the pathogenesis of MSMD and must be considered in pediatric patients with BCGitis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:MSMD · BCGitis · tüm ekzom dizileme

Abstract

Objective: Mendelian susceptibility to mycobacterial disease (MSMD) is a subgroup of primary immunodeficiencies which develops with the Bacille Calmette–Guérin (BCG) vaccine or non-tuberculous mycobacterial infections. The clinical symptoms have a broad spectrum, from localized to disseminated infections. Materials and Methods: Herein, we performed whole-exome sequencing (WES) on 13 patients with MSMD phenotype. All variants were confirmed by Sanger sequencing. The mean age was 8.41 years (min 3 – max 14 years), and the mean age of symptom onset was 4.6 years in our cohort. Results: We found previously identified IFNGR1 (n=1), IFNGR2 (n=1), TYK2 (n=1), IL12RB1 (n=1), and CYBB (n=1) gene variants in nine patients. Our patients mostly suffered from lymphadenitis (61.5%), osteomyelitis (38%), and miliary tuberculosis (31%). All patients except one had had the BCG vaccination. Two patients developed BCGitis after vaccination. Three patients suffered from disseminated BCG infection (BCGosis). Conclusion: Our findings show the importance of molecular diagnosis in patients with severe infections as an approach for understanding the genetic basis of infectious diseases and deciding on treatment options. The deficiency of IFN-mediated immunity genes plays a crucial role in the pathogenesis of MSMD and must be considered in pediatric patients with BCGitis.

Özet

Amaç: Mikobakteriyel hastalığa (MSMD) Mendel duyarlılığı, Bacille Calmette-Guérin (BCG) aşısı veya tüberküloz dışı mikobakteriyel enfeksiyonlarla gelişen primer immün yetmezliklerin bir alt grubudur. Klinik semptomlar, lokalize enfeksiyondan yayılmış enfeksiyona kadar geniş bir spektruma sahiptir. Gereç ve Yöntem: Bu çalışmada; MSMD fenotipli 13 hastada tüm ekzom dizileme (WES) yaptık. Tüm varyantlar Sanger dizileme ile doğrulandı. Bizim kohortumuzda ortalama yaş 8.41 yıl (en az 3 – en fazla 14 yıl) ve ortalama semptom başlangıç yaşı 4.6 idi. Bulgular: Dokuz hastada; IFNGR1 (n=2), IFNGR2 (n=1), TYK2 (n=1), IL12RB1 (n=1) ve CYBB (n=1) gen varyantları bulduk. Hastalarımızda en çok lenfadenit (%61,5), osteomiyelit (%38) ve miliyer tüberküloz (%31) mevcuttu. Biri hariç tüm hastalara BCG aşısı yapıldı. İki hastada aşılamadan sonra BCGitis gelişti. Üç hasta, yayılmış BCG enfeksiyonundan (BCGosis) muzdaripti. Sonuç: Bulgularımız, enfeksiyon hastalıklarının genetik temelinin anlaşılmasında ve tedavi seçeneklerine karar verilmesinde bir yaklaşım olarak ağır enfeksiyonlu hastalarda moleküler tanının önemini göstermektedir. IFN aracılı bağışıklık genlerinin eksikliği, MSMD’nin patogenezinde çok önemli bir rol oynar ve BCGitis’li pediatrik hastalarda düşünülmelidir.

🔖

Cite This Article

NEPESOV, S., FIRTINA, S., AYGÜN, D., IŞIKGİL, B., CAMCIOĞLU, Y., KIYKIM, A., ÖZEK, E., DEMİRKOL, Y. K., AYAZ, A. (2022). GENETIC AND CLINICAL PROFILING OF MENDELIAN SUSCEPTIBILITY TO MYCOBACTERIAL DISEASE PATIENTS; SINGLECENTER EXPERIENCE. Sağlık Bilimlerinde İleri Araştırmalar Dergisi, Cilt: 5 - Sayı: 3, 140–146. https://ajindex.com/articles/888379

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Soyak Aytekin E, Keskin A, Tan C, Yalçın E, Dogru D, Ozcelik U, et al. Differential diagnosis of primary immunodeficiency in patients with BCGitis and BCGosis: A single-centre study. Scand J İmmunol 2021
  2. 94(4):e13084. doi: 10.1111/sji.13084. google scholar 2. Bustamante J. Mendelian susceptibility to mycobacterial disease: recent discoveries. Hum Genet 2020
  3. 139(6-7):993-1000. google scholar 3. Rosain J, Kong XF, Martinez-Barricarte R, Oleaga-Quintas C, Ramirez-Alejo N, Markle J, et al. Mendelian susceptibility to mycobacterial disease: 2014-2018 update. İmmunol Cell Biol 2019
  4. 97(4):360-7. google scholar 4. Das J, Banday AZ, Shandilya J, Sharma M, Vignesh P, Rawat A. An updated review on Mendelian susceptibility to mycobacterial diseases- a silver jubilee celebration of its first genetic diagnosis. Expert Rev Clin İmmunol 2021
  5. 17(10):1103-20. google scholar 5. Filipe-Santos O, Bustamante J, Chapgier A, Vogt G, Beaucoudrey L de, Feinberg J, et al. İnborn errors of İL-12/23- and İFN-gamma-mediated immunity: molecular, cellular, and clinical features. Semin İmmunol 2006
  6. 18(6):347-61. google scholar 6. Zhou X, Jia W, Ni Z, Wang A, Liu Z, Hou M, et al. Three novel compound heterozygous İL12RB1 mutations in Chinese patients with Mendelian susceptibility to mycobacterial disease. PLoS One 2019
  7. 14(4):e0215648. doi: 10.1371/journal.pone.0215648. google scholar 7. Tan C, Cagdas-Ayvaz D, Metin A, Keskin O, Tezcan İ, Sanal O. Clinical and genetic features of IL12Rb1 deficiency: Single center experience of 18 patients. Turk J Pediatr 2016
  8. 58(4):356-61. google scholar 8. Kerner G, Rosain J, Guerin A, Al-Khabaz A, Oleaga-Quintas C, Rapaport F, et al. Inherited human IFN-gamma deficiency underlies mycobacterial disease. J Clin Invest 2020
  9. 130(6):3158-71. google scholar 9. van de Vosse E, van Dissel JT. IFN-gammaR1 defects: Mutation update and description of the IFNGR1 variation database. Hum Mutat 2017
  10. 38(10):1286-96. google scholar 10. Indumathi CK, Bustamante J. Clinical and immunological profile of children with Mendelian Susceptibility to Mycobacterial Diseases (MSMD) from an Indian tertiary care hospital. Indian J Tuberc 2021
  11. 68(2):292-7. google scholar 11. Boisson-Dupuis S, Ramirez-Alejo N, Li Z, Rao G, Kerner G, Lim CK et al. Tuberculosis and impaired IL-23-dependent IFN-gamma immunity in humans homozygous for a common TYK2 missense variant. Sci Immunol 2018
  12. 3(30):eaau8714. doi: 10.1126/ sciimmunol.aau8714. google scholar 12. Wu P, Chen S, Wu B, Chen J, Lv G. A